Results of a Screening Study of Tumor Markers (REA, CA 19-9, PSA, CA15-3) among the Population in South Yakutia

被引：0

作者：

Antipina, Ulyana D. ^{[1
]}

Markova, Sardana, V ^{[1
]}

Borisova, Natalia, V ^{[1
]}

Alekseeva, Sardana N. ^{[1
]}

Malogulova, Irina Sh ^{[1
]}

Sivtseva, Tyuaara P. ^{[1
]}

Yadrikhinskaya, Vera N. ^{[1
]}

Yadrikhinskaya, Evgenia E. ^{[1
]}

机构：

[1] MK Ammosov North Eastern Fed Univ, The Republic Of Sakha, Yakutia, Russia

来源：

INTERNATIONAL JOURNAL OF BIOMEDICINE | 2019年 / 9卷 / 03期

关键词：

cancer; pathology; oncology; screening research; damage; CLINICAL UTILITY; DIAGNOSIS; ANTIGEN; CANCER; SERUM;

D O I：

10.21103/Article9(3)_OA6

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Early cancer screening is the most effective way to reduce cancer mortality. The number of potentially viable tumor markers (TMs) is rapidly expanding and promises further improvement in sensitivity and specificity. The article presents the results of a population-based study of screening for the most common types of cancer in individuals living in South Yakutia.

引用

页码：220 / 222

页数：3

共 50 条

[41] THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3 AND CEA IN OVARIAN-CANCER
HOFFMANN, L
MULLERHAGEN, S
FRANZ, G
KLAPDOR, R
DIETEL, M
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 371 - 372
[42] CARBOHYDRATE ANTIGENIC DETERMINANT (CA 19-9) AND OTHER TUMOR-MARKERS IN GASTROINTESTINAL MALIGNANCIES
YOSHIKAWA, T
NISHIDA, K
TANIGAWA, M
FUKUMOTO, K
KONDO, M
DIGESTION, 1985, 31 (2-3) : 67 - 76
[43] Tumor markers for pancreatic cancer: What happens when preoperative CA 19-9 is undetectable?
Bouvet, M
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (07) : 637 - 638
[44] A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
Hogendorf, Piotr
Skulimowski, Aleksander
Durczynski, Adam
Kumor, Anna
Poznanska, Grahyna
Olesna, Aleksandra
Rut, Joanna
Strzelczyk, Janusz
DISEASE MARKERS, 2017, 2017
[45] Maternal serum CA 19-9 and CA 15-3 levels in pregnancies affected by trisomy 21
Akinlade, F.
Cowans, N. J.
Kisanga, M. C.
Spencer, K.
PRENATAL DIAGNOSIS, 2012, 32 (07) : 644 - 648
[46] Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis
Shen, Airong
Xu, Shengnan
Ma, Yange
Guo, Huanhuan
Li, Canyu
Yang, Chunli
Zou, Shunhong
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2015, 43 (05) : 599 - 609
[47] EVALUATION OF 7 TUMOR-MARKERS (CA 50, CA 19-9, CA 19-9 TRUQUANT, CA 72-4, CA 195, CARCINOEMBRYONIC ANTIGEN, AND TISSUE POLYPEPTIDE ANTIGEN) IN THE PRETREATMENT SERA OF PATIENTS WITH GASTRIC-CARCINOMA
WOBBES, T
THOMAS, CMG
SEGERS, MFG
NAGENGAST, FM
CANCER, 1992, 69 (08) : 2036 - 2041
[48] EPITHELIAL TUMOR MARKERS (CA 125, CA 19-9 AND CEA) TRENDS IN PATIENTS UNDERGOING TREATMENT FOR INVASIVE BLADDER CANCER
Bazargani, Soroush T.
Shah, Swar
Ahmadi, Hamed
Schuckman, Anne
Cai, Jie
Miranda, Gus
Dorff, Tanya
Sadeghi, Sarmad
Quinn, David
Djaladat, Hooman
Daneshmand, Siamak
JOURNAL OF UROLOGY, 2015, 193 (04): : E483 - E484
[49] Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation
Spila, A
Ferroni, P
Cosimelli, M
D'Alessandro, R
Abbolito, MR
Mariotti, S
Aloe, S
Carone, MD
Graziano, F
Tedesco, M
Martin, F
Mancini, R
Stigliano, V
Roselli, M
Guadagni, F
ANTICANCER RESEARCH, 2001, 21 (2B) : 1263 - 1270
[50] RAPID DIAGNOSIS OF PANCREATIC-CANCER BY COMBINATION OF ULTRASONOGRAPHY AND SERUM TUMOR-MARKERS CA 19-9 AND CA 50
BOVO, P
RIGO, L
TOGNI, M
MONTESI, G
DIFRANCESCO, V
BRUNORI, MP
ANGELINI, G
FRULLONI, L
MARCORI, M
CAVALLINI, G
ITALIAN JOURNAL OF GASTROENTEROLOGY, 1993, 25 (09): : 477 - 481

← 1 2 3 4 5 →